Regeneron Pharmaceuticals | REGN - Stock

Aktienkurs
707.06
Täglich Wechseln
20.70 3.02%
Monatlich
-8.49%
Jährlich
19.84%
Q2 Prognose
735.49




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.22B 121M 2025-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.57B 13M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Gilead Sciences USD 1.77B 11M 2025-12
GlaxoSmithKline GBP 6.16B 233M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
J&J USD 14.58B 392M 2026-03
Kyowa Hakko Kirin JPY 72.86B 304M 2025-06
Merck USD 6.66B 214M 2025-12
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.27B 152M 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12